Tilray | TRLY - Loan Capital



Tilray reported $316.63M in Loan Capital for its fiscal quarter ending in November of 2024.


Loan Capital Change Date
Acasti Pharma USD 0 0 Dec/2024
Alaunos Therapeutics USD 0 0 Dec/2024
Aurora Cannabis CAD 36.3M 3.89M Jun/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Canopy Growth CAD 289M 178.93M Jun/2025
Cronos Group USD 0 0 Mar/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd 20M 0 Mar/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Moderna USD 32M 3M Jun/2025
Organigram Holdings CAD 52.8M 9.51M Jun/2025
Organon & Co USD 8.9B 36M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Tectonic Therapeutic USD 186K 201K Jun/2025
Tilray USD 316.63M 15.02M Nov/2024
Viatris USD 12.79B 1.39B Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025